A Comparative clinical study to evaluate the efficacy of Paarthadi Kwath along with Hridbasti and calcium channel blocker on Essential Hypertension

DPU Seed Money with letter no DP0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1. 18-70 years of either gender.
•2. Systolic Blood pressure less than 170mmHg more than or equal to 140mmHg.
•3. Distolic Blood Pressure less thann or equal to 110mmHg and more than 90mmHg.
•4. Hypertension Stage II according to JNC seventh report 2004.

•1. Patient that past history of atrial fibrillation, acute coronary syndrome ,myocardial infarction, stroke, right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia in last 6 months.
•2. Symptomatic patient with clinical feature of early heart failure.
•3. Secondary hypertension.
•4. Patient with concurrent serious hepatic dysfunction, renal dysfunction, uncontrolled pulmonary dysfunction.
•5. Patient suffering with diabetes nephropathy.
•6. Women who are pregnant, lactating or on estrogen replacement therapy.
•7. Alcohol and Drug abusers.
•8. Accelerated and maligant hypertension.

发起方

DPU Seed Money with letter no DP